These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11504989)

  • 1. 'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.
    Weber J; Nunn A; O'Connor T; Jeffries D; Kitchen V; McCormack S; Stott J; Almond N; Stone A; Darbyshire J
    AIDS; 2001 Aug; 15(12):1563-8. PubMed ID: 11504989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
    Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
    J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
    Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
    J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.
    Cong ME; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2016; 11(11):e0164821. PubMed ID: 27806064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
    Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.
    Andrews CD; Yueh YL; Spreen WR; St Bernard L; Boente-Carrera M; Rodriguez K; Gettie A; Russell-Lodrigue K; Blanchard J; Ford S; Mohri H; Cheng-Mayer C; Hong Z; Ho DD; Markowitz M
    Sci Transl Med; 2015 Jan; 7(270):270ra4. PubMed ID: 25589630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models.
    Tsai CC; Emau P; Jiang Y; Agy MB; Shattock RJ; Schmidt A; Morton WR; Gustafson KR; Boyd MR
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):11-8. PubMed ID: 15000694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
    Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques.
    Dobard CW; Sharma S; Cong ME; West R; Makarova N; Holder A; Pau CP; Hanson DL; Novembre FJ; Garcia-Lerma JG; Heneine W
    Retrovirology; 2015 Aug; 12():69. PubMed ID: 26253002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
    Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
    Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
    Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
    Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
    Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.
    Nuttall J; Kashuba A; Wang R; White N; Allen P; Roberts J; Romano J
    Antimicrob Agents Chemother; 2012 Jan; 56(1):103-9. PubMed ID: 21986823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.